Janet Jackim (Courtesy photo)
(This is a contributed guest column. To be considered as an MJBizDaily guest columnist, please submit your request here.)
President Donald Trump’s Dec. 18 executive order directed U.S. Attorney General Pam Bondi to take “all necessary steps” to move marijuana to Schedule 3 of the Controlled Substances Act. It also encouraged medical marijuana research, testing and use.
For healthcare providers and legal marijuana businesses, federal marijuana rescheduling marks a potentially significant shift in how medical cannabis may be researched, regulated, prescribed, and commercialized at the federal level.
But medical is the key word here. Near-term federal policy changes are expected to apply only to cannabis used for legitimate medical purposes, not adult use.
ADVERTISEMENT
President Trump’s kind words for
Read full article on Marijuana Business Daily
